<DOC>
	<DOC>NCT02734628</DOC>
	<brief_summary>The objective of the study was to investigate the efficacy of BepanthenÂ® wound healing ointment compared to placebo in a superficial abrasive wound model. The primary objective was the re-epithelization at Day 5. The secondary objectives were re-epithelization at Days 2, 3, 4, 6, 7, 8, 9, 10 and 15, assessment of cosmetic outcome/acceptance at Day 15 (investigator only) and at Day 36 (investigator and subject), and documentation and analysis of safety parameters.</brief_summary>
	<brief_title>Pilot Study to Assess Number of Patients for Main Trial</brief_title>
	<detailed_description />
	<mesh_term>Pantothenic Acid</mesh_term>
	<criteria>Healthy Caucasian subjects of both genders, 18 to 45 years of age, Fitzpatrick skin type I to IV Active skin disease, moles, tattoos, strong pigmentation at the test area or scars in the test area that would influence the visual scoring History of keloids and hypertrophic scars History of plaster sensitivity Intake of drugs interfering with the immune system within 30 days before day 1 as well as during the study Concomitant therapy with substances affecting blood coagulation within up to 14 days prior to the start of the study as well as during the study Any condition or treatment which might influence the study Change of hormonal contraception within 3 months prior to enrolment and during the study Application of any topical treatment at the test areas during the conduct of the study Intensive ultravioletlight exposure within two weeks before the beginning as well as during the study Removal of axillary lymph nodes Allergy to the ingredients of the test product Pregnancy or lactation Any illness on account of which the subject should not participate in the study in the opinion of the investigator Psychiatric conditions that might limit the participation in the trial and/or that lead to the assumption that the ability to completely understand the consequences of consent is missing Any history of drug addiction or alcoholism in the past 3 years Infectious diseases (e.g. hepatitis or AIDS)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>